Related references
Note: Only part of the references are listed.Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease
Gerd R. Burmester et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Two-Year Randomized Controlled Prospective Trial Converting Treatment of Stable Renal Transplant Recipients With Cutaneous Invasive Squamous Cell Carcinomas to Sirolimus
Judith M. Hoogendijk-van den Akker et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion
M. -A. Richard et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype
Robert P. Carroll et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Reversal of UVA Skin Photosensitivity and DNA Damage in Kidney Transplant Recipients by Replacing Azathioprine
G. F. L. Hofbauer et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Management of Non-Melanoma Skin Cancer in Immunocompromised Solid Organ Transplant Recipients
Haider K. Bangash et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2012)
Therapeutic Options to Decrease Actinic Keratosis and Squamous Cell Carcinoma Incidence and Progression in Solid Organ Transplant Recipients: A Practical Approach
Simon A. Ritchie et al.
DERMATOLOGIC SURGERY (2012)
Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease
Millie D. Long et al.
GASTROENTEROLOGY (2012)
Combined introduction of anti-IL2 receptor antibodies, mycophenolic acid and tacrolimus: effect on malignancies after renal transplantation in a single-centre retrospective cohort
Philippe Braconnier et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation
Sylvie Euvrard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Skin Cancer in Transplant Recipients, Out of the Woods. Scientific Retreat of the ITSCC and SCOPE
O. R. Colegio et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease
Daniel Wolff et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Management of Skin Cancer in Solid-organ Transplant Recipients: A Multidisciplinary Approach
Judah N. Greenberg et al.
DERMATOLOGIC CLINICS (2011)
Skin cancer in solid organ transplant recipients: Advances in therapy and management Part II. Management of skin cancer in solid organ transplant recipients
Fiona O'Reilly Zwald et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Skin cancer in solid organ transplant recipients: Advances in therapy and management Part I. Epidemiology of skin cancer in solid organ transplant recipients
Fiona O'Reilly Zwald et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data
Johan Askling et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Lower Malignancy Rates in Renal Allograft Recipients Converted to Sirolimus-Based, Calcineurin Inhibitor-Free Immunotherapy: 24-Month Results From the CONVERT Trial
Josefina Alberu et al.
TRANSPLANTATION (2011)
Switch to a Sirolimus-Based Immunosuppression in Long-Term Renal Transplant Recipients: Reduced Rate of (Pre-)Malignancies and Nonmelanoma Skin Cancer in a Prospective, Randomized, Assessor-Blinded, Controlled Clinical Trial
R. Salgo et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry Audit
D. Collett et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Cyclosporine A suppresses keratinocyte cell death through MPTP inhibition in a model for skin cancer in organ transplant recipients
Kimberly G. Norman et al.
MITOCHONDRION (2010)
Opposing roles for calcineurin and ATF3 in squamous skin cancer
Xunwei Wu et al.
NATURE (2010)
Solid cancers after allogeneic hematopoietic cell transplantation
J. Douglas Rizzo et al.
BLOOD (2009)
Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study
C. Ulrich et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Skin cancer in organ transplant recipients -: Where do we stand today?
C. Ulrich et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Reduction of immunosuppression for transplant-associated skin cancer: thresholds and risks
C. C. Otley et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Topical photodynamic therapy of actinic keratosis in renal transplant recipients
S. Piaserico et al.
TRANSPLANTATION PROCEEDINGS (2007)
Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy
C. M. Perrett et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Baseline quality of life and anxiety in solid organ transplant recipients: A pilot study
Fiona O'Reilly et al.
DERMATOLOGIC SURGERY (2006)
Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awareness
F. Ismail et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: Analysis of the transplant registry of the International Society for Heart and Lung Transplantation
James O. O'Neill et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2006)
Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases
C. Ulrich et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Special concern about squamous cell carcinoma of the scalp in organ transplant recipients
JZ Cooper et al.
ARCHIVES OF DERMATOLOGY (2006)
Educational outcomes regarding skin cancer in organ transplant recipients - Randomized intervention of intensive vs standard education
Holly E. Clowers-Webb et al.
ARCHIVES OF DERMATOLOGY (2006)
Survival signaling by Notch1: Mammalian target of rapamycin (mTOR)-dependent inhibition of p53
Sathish Kumar Mungamuri et al.
CANCER RESEARCH (2006)
Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey
CC Otley et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation
W Leisenring et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Mortality and clinicopathological features of cutaneous squamous cell carcinoma in organ transplant recipients: A study of the Swedish cohort
Bernt Lindelof et al.
ACTA DERMATO-VENEREOLOGICA (2006)
Azathioprine and UVA light generate mutagenic oxidative DNA damage
P O'Donovan et al.
SCIENCE (2005)
The impact of skin disease following renal transplantation on quality of life
FJ Moloney et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients - Randomized, double-blind, placebo-controlled trial
VL Brown et al.
ARCHIVES OF DERMATOLOGY (2005)
Low-dose Retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients - A 16-year retrospective study
CA Harwood et al.
ARCHIVES OF DERMATOLOGY (2005)
Reduction of immunosuppression for transplant-associated skin cancer: Rationale and evidence of efficacy
CC Otley et al.
DERMATOLOGIC SURGERY (2005)
Renal-transplant recipients and sun protection
E Mahé et al.
TRANSPLANTATION (2004)
Tumor necrosis factor-α blockade for the treatment of acute GVHD
D Couriel et al.
BLOOD (2004)
Medical progress - Skin cancers after organ transplantation
S Euvrard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Defining the clinical course of metastatic skin cancer in organ transplant recipients - A multicenter collaborative study
JC Martinez et al.
ARCHIVES OF DERMATOLOGY (2003)
Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management
D Berg et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease
KY Chiang et al.
TRANSPLANTATION (2002)
Post-transplant malignancy - The role of immunosuppression
I Penn
DRUG SAFETY (2000)
Organization of a specialty clinic to optimize the care of organ transplant recipients at risk for skin cancer
CC Otley
DERMATOLOGIC SURGERY (2000)